This privacy notice is provided by Chiesi Farmaceutici S.p.A. ("Chiesi"), in accordance with the provisions of the Regulation EU 679/2016 (hereinafter "GDPR"), to inform you about the processing of personal data of the users visiting the following website: www.rethinkfabry.net.
No personal data relating to the users will be processed when they access and browse the website.
The computer systems and software procedures used to operate this site acquire, during their normal operation, some personal data whose transmission is implicit in the use of internet communication protocols.
This information is not collected to be associated with identified data subjects, but, because of their operating nature, could, through processing and associations with data held by third parties, allow users to be identified.
This category of data includes the IP address or the domain name of the computers used by the data subjects connecting to the website, the URI (Uniform Resource Identifier) address, the time of the request, the method utilized to submit the request to the server, the size of the file received in response, the numerical code indicating the status of the response from the server (successful, error, etc.), and other parameters relating to the operating system and the user’s IT environment.
This data is used for the sole purpose of obtaining anonymous statistical information on the use of the site, to check its proper functioning, and is maintained for the minimum period required by current legislation.
This data could be used to assess the liability in case of eventual computer crimes against the site.
The optional, explicit, and voluntary act of sending emails to the addresses eventually indicated in this site entails the subsequent acquisition of the sender’s address, necessary in order to reply to the requests, as well as of any other personal data therein reported. The processing of sensitive and judicial data is excluded and, if provided by the user, will be deleted.
Chiesi Farmaceutici S.p.A. has appointed a Data Protection Officer pursuant to Article 37 of the GDPR whocan be contacted at the email address firstname.lastname@example.org.
This website is intended to inform healthcare professionals about the pathogenesis of Fabry disease and to provide insights in the burden of this disease. With this information we strive to support and where possible enhance the treatment of patients suffering from this debilitating disease.
You are now leaving Rethink Fabry. Please note that the site you are entering is not the property of nor managed by Chiesi.